Quantitative SPECT/CT for dosimetry of peptide receptor radionuclide therapy
J Kennedy, A Chicheportiche, Z Keidar - Seminars in nuclear medicine, 2022 - Elsevier
Neuroendocrine tumors (NETs) are uncommon malignancies of increasing incidence and
prevalence. As these slow growing tumors usually overexpress somatostatin receptors …
prevalence. As these slow growing tumors usually overexpress somatostatin receptors …
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy.
J Kennedy, A Chicheportiche… - Seminars in Nuclear …, 2021 - europepmc.org
Neuroendocrine tumors (NETs) are uncommon malignancies of increasing incidence and
prevalence. As these slow growing tumors usually overexpress somatostatin receptors …
prevalence. As these slow growing tumors usually overexpress somatostatin receptors …
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy
J Kennedy, A Chicheportiche… - Seminars in nuclear …, 2022 - pubmed.ncbi.nlm.nih.gov
Neuroendocrine tumors (NETs) are uncommon malignancies of increasing incidence and
prevalence. As these slow growing tumors usually overexpress somatostatin receptors …
prevalence. As these slow growing tumors usually overexpress somatostatin receptors …